Lineage, Inc. Common Stock (LINE)vsSL Green Realty Corp (SLG)
LINE
Lineage, Inc. Common Stock
$37.04
+0.43%
REAL ESTATE · Cap: $8.93B
SLG
SL Green Realty Corp
$42.41
-3.28%
REAL ESTATE · Cap: $3.03B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 471% more annual revenue ($5.36B vs $938.19M). LINE leads profitability with a -1.9% profit margin vs -16.2%. SLG earns a higher WallStSmart Score of 42/100 (D).
LINE
Hold36
out of 100
Grade: F
SLG
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+75.9%
Fair Value
$161.49
Current Price
$37.04
$124.45 discount
Margin of Safety
+55.2%
Fair Value
$90.36
Current Price
$42.41
$47.95 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
ROE of -1.2% — below average capital efficiency
Revenue declined 0.2%
Distress zone — elevated risk
Operating margin of 1.7%
ROE of -3.5% — below average capital efficiency
Revenue declined 3.6%
Earnings declined 98.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : SLG
The strongest argument for SLG centers on Price/Book. PEG of 1.30 suggests the stock is reasonably priced for its growth.
Bear Case : LINE
The primary concerns for LINE are EPS Growth, Return on Equity, Revenue Growth.
Bear Case : SLG
The primary concerns for SLG are Operating Margin, Return on Equity, Revenue Growth.
Key Dynamics to Monitor
LINE is growing revenue faster at -0.2% — sustainability is the question.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SLG scores higher overall (42/100 vs 36/100). LINE offers better value entry with a 75.9% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm focused on regenerative medicine, specifically developing cutting-edge cell therapy solutions for treating debilitating conditions, including ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust network of strategic collaborations, Lineage is poised to transform patient care through innovative therapeutic interventions. The company's commitment to advancing its diverse product pipeline and expediting clinical research positions it as an attractive investment opportunity for institutional investors seeking to engage in the forefront of healthcare advancements.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?